Supernus Pharmaceuticals (NASDAQ: SUPN) recently received a number of ratings updates from brokerages and research firms: 12/19/2025 – Supernus Pharmaceuticals had its price target raised by analysts at Stifel Nicolaus from $50.00 to $55.00. They now have a “hold” rating on the stock. 12/15/2025 – Supernus Pharmaceuticals had its “sell (d+)” rating reaffirmed by analysts […]

Several brokerages have updated their recommendations and price targets on shares of Healthcare Services Group (NASDAQ: HCSG) in the last few weeks: 12/8/2025 – Healthcare Services Group had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings. 12/6/2025 – Healthcare Services Group was upgraded by analysts at Wall Street Zen from a “buy” rating […]